Collegium Pharma (COLL)

$22.75 -0.17 (-0.74%)
Market Cap 740.65M
Revenue (ttm) 780.57M
Net Income (ttm) 62.87M
EPS (ttm) N/A
PE Ratio 3.28
Forward PE 3.70
Profit Margin 8.05%
Debt to Equity Ratio 2.73
Volume 661,300
Avg Vol 678,488
Day's Range N/A - N/A
Shares Out 32.56M
Stochastic %K 4%
Beta 0.72
Analysts Strong Sell
Price Target $48.86

Company Profile

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-dete...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 781 713 3699
Address:
100 Technology Center Drive, Suite 300, Stoughton, United States
JR603
JR603 Sep. 10 at 4:01 PM
$COLL YIKES !
0 · Reply
lolloalb
lolloalb Aug. 31 at 8:16 PM
$COLL No sense… this company is seriously undervalued. The current share price simply doesn’t reflect the strength of the business, its cash generation and the value of its portfolio. The recent sell-off looks completely disconnected from the underlying fundamentals. At these levels, the market seems to be pricing in a much worse scenario than the one the company is actually facing. Long-term, I still believe there is significant upside.
0 · Reply
JR603
JR603 Aug. 31 at 4:38 PM
$COLL Holly Molly ...... does this mean another $50M buyback is coming next? Why is this company so unappreciated and unrecognized?
0 · Reply
jewell69
jewell69 Aug. 27 at 5:04 PM
yo me llamo "Claire Voyant" $COLL re-entry today. s yesterday. 08/27/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 352 $26.58 -$9,356.16 More 08/26/2026 Sell Edit cost basis method COLL COLLEGIUM PHARMACEUTICAL 351 $28.04 $0.27 $9,841.77 More 08/25/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 351 $27.58 -$9,680.58 More 08/24/2026 Sell COLL COLLEGIUM PHARMACEUTICAL 350 $27.80 $0.27 $9,729.73 More 08/20/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 350 $27.74 -$9,709.00 More 08/18/2026 Sell COLL COLLEGIUM PHARMACEUTICAL 30 $28.34 $0.03 $850.17 More 08/17/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 30 $28.25 -$847.50 More 08/17/2026 Sell COLL COLLEGIUM PHARMACEUTICAL 201 $28.85 $0.16 $5,798.69 More 08/14/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 201 $27.98 -$5,623.98
0 · Reply
jewell69
jewell69 Aug. 26 at 3:08 PM
$COLL s 351 28.04 11:03 am edt 8/26 (horray ! limit order placed at 27.98 ) paid 27.58 yesterday
0 · Reply
jewell69
jewell69 Aug. 25 at 5:20 PM
$COLL narrow trading range, UGH ! Got Opium ? re-entry. ps we were trading this in the 43's not 2 long ago 08/25/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 351 $27.58 -$9,680.58 More 08/24/2026 Sell Edit cost basis method COLL COLLEGIUM PHARMACEUTICAL 350 $27.80 $0.27 $9,729.73 More 08/20/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 350 $27.74 -$9,709.00
0 · Reply
CHenry18
CHenry18 Aug. 25 at 1:20 AM
$COLL millenium just doubled its long position and filed a 13G
0 · Reply
jewell69
jewell69 Aug. 20 at 4:12 PM
$COLL Got Opium ? re-entry 12:11 pm edt 8/20 bigger position this time around. 08/20/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 350 $27.74 -$9,709.00 More 08/18/2026 Sell COLL COLLEGIUM PHARMACEUTICAL 30 $28.34 $0.03 $850.17 More 08/17/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 30 $28.25 -$847.50 More 08/17/2026 Sell COLL COLLEGIUM PHARMACEUTICAL 201 $28.85 $0.16 $5,798.69 More 08/14/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 201 $27.98 -$5,623.98 More 08/13/2026 Sell COLL COLLEGIUM PHARMACEUTICAL 200 $28.32 $0.16 $5,663.84
0 · Reply
jewell69
jewell69 Aug. 13 at 7:13 PM
$COLL catching a falling knife SOMETIMES results in bloody hands. lost on this one. fwiw we b 100 during the day, and b 100 on a mkt on close order. GOT OPIUM ? non-addictive pain medicine. 2 hot 2 handle (it was at 44 in early february) 08/13/2026 Sell Edit cost basis method COLL COLLEGIUM PHARMACEUTICAL 200 $28.32 $0.16 $5,663.84 More 08/06/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 100 $29.11 -$2,911.00 More 08/06/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 100 $30.28 -$3,028.00
0 · Reply
DutchGolden
DutchGolden Aug. 13 at 7:09 PM
$COLL why are options so expensive for a $20 stock
1 · Reply
Latest News on COLL
Leerink bullish on Collegium Pharmaceutical, initiates with an Outperform

2026-09-09T12:21:18.000Z - 4 days ago

Leerink bullish on Collegium Pharmaceutical, initiates with an Outperform

Collegium Pharmaceutical initiated with an Outperform at Leerink

2026-09-09T10:15:30.000Z - 4 days ago

Collegium Pharmaceutical initiated with an Outperform at Leerink

Collegium Pharmaceutical assumed with a Buy at Truist

2026-09-09T10:11:02.000Z - 4 days ago

Collegium Pharmaceutical assumed with a Buy at Truist

Collegium to Participate in Upcoming Investor Conferences

Sep 8, 2026, 8:00 AM EDT - 5 days ago

Collegium to Participate in Upcoming Investor Conferences

Collegium Pharmaceutical price target lowered to $48 from $56 at Barclays

2026-08-19T09:25:08.000Z - 25 days ago

Collegium Pharmaceutical price target lowered to $48 from $56 at Barclays

Collegium Announces $50 Million Accelerated Share Repurchase Program

Aug 13, 2026, 7:30 AM EDT - 4 weeks ago

Collegium Announces $50 Million Accelerated Share Repurchase Program

Collegium Pharmaceutical Earnings Call Transcript: Q2 2026

Aug 6, 2026, 8:00 AM EDT - 5 weeks ago

Collegium Pharmaceutical Earnings Call Transcript: Q2 2026

Collegium Pharmaceutical Quarterly report: Q2 2026

Aug 6, 2026, 8:00 AM EDT - 5 weeks ago

Collegium Pharmaceutical Quarterly report: Q2 2026

Collegium Pharmaceutical Earnings release: Q2 2026

Aug 6, 2026, 8:00 AM EDT - 5 weeks ago

Collegium Pharmaceutical Earnings release: Q2 2026

Collegium Pharmaceutical Slides: Q2 2026

Aug 6, 2026, 8:00 AM EDT - 5 weeks ago

Collegium Pharmaceutical Slides: Q2 2026

Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress

Aug 6, 2026, 7:30 AM EDT - 5 weeks ago

Collegium Reports Second Quarter 2026 Financial Results and Highlights Recent Company Progress

Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026

Jul 23, 2026, 8:00 AM EDT - 7 weeks ago

Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026

DivcoWest Welcomes Collegium Pharmaceutical to One Lincoln

Jul 20, 2026, 8:33 AM EDT - 7 weeks ago

DivcoWest Welcomes Collegium Pharmaceutical to One Lincoln

Collegium Pharmaceutical to relocate corporate headquarters to Boston

2026-07-20T12:05:12.000Z - 7 weeks ago

Collegium Pharmaceutical to relocate corporate headquarters to Boston

Collegium Pharmaceutical Announces New Corporate Headquarters at One Lincoln in Boston

Jul 20, 2026, 8:00 AM EDT - 7 weeks ago

Collegium Pharmaceutical Announces New Corporate Headquarters at One Lincoln in Boston

Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jun 5, 2026, 8:00 AM EDT - 3 months ago

Collegium Pharmaceutical Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Collegium Pharmaceutical Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 1:20 PM EDT - 3 months ago

Collegium Pharmaceutical Transcript: Jefferies Global Healthcare Conference 2026

Collegium to Participate in 2026 Jefferies Global Healthcare Conference

May 27, 2026, 8:00 AM EDT - 3 months ago

Collegium to Participate in 2026 Jefferies Global Healthcare Conference

Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics

May 12, 2026, 7:31 AM EDT - 4 months ago

Collegium Completes Acquisition of AZSTARYS® from Corium Therapeutics

Collegium Pharmaceutical reports Q1 EPS $1.76, consensus $1.52

2026-05-07T12:35:00.000Z - 4 months ago

Collegium Pharmaceutical reports Q1 EPS $1.76, consensus $1.52

Collegium Pharmaceutical backs FY26 revenue view $805M-$825M, consensus $839.15M

2026-05-07T12:32:30.000Z - 4 months ago

Collegium Pharmaceutical backs FY26 revenue view $805M-$825M, consensus $839.15M

Collegium Pharmaceutical Earnings Call Transcript: Q1 2026

May 7, 2026, 8:00 AM EDT - 4 months ago

Collegium Pharmaceutical Earnings Call Transcript: Q1 2026

Collegium Pharmaceutical Earnings release: Q1 2026

May 7, 2026, 8:00 AM EDT - 4 months ago

Collegium Pharmaceutical Earnings release: Q1 2026

Collegium Pharmaceutical Quarterly report: Q1 2026

May 7, 2026, 8:00 AM EDT - 4 months ago

Collegium Pharmaceutical Quarterly report: Q1 2026

Collegium Pharmaceutical Slides: Q1 2026

May 7, 2026, 8:00 AM EDT - 4 months ago

Collegium Pharmaceutical Slides: Q1 2026

Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress

May 7, 2026, 7:30 AM EDT - 4 months ago

Collegium Reports First Quarter 2026 Financial Results and Highlights Recent Company Progress

Collegium to Report First Quarter 2026 Financial Results on May 7, 2026

Apr 23, 2026, 8:00 AM EDT - 4 months ago

Collegium to Report First Quarter 2026 Financial Results on May 7, 2026

Collegium Pharmaceutical Transcript: 25th Annual Needham Virtual Healthcare Conference

Apr 15, 2026, 2:15 PM EDT - 5 months ago

Collegium Pharmaceutical Transcript: 25th Annual Needham Virtual Healthcare Conference

Collegium Pharmaceutical Proxy statement: Proxy filing

Apr 7, 2026, 8:00 AM EDT - 5 months ago

Collegium Pharmaceutical Proxy statement: Proxy filing

Collegium Pharmaceutical Transcript: M&A announcement

Mar 19, 2026, 9:00 AM EDT - 5 months ago

Collegium Pharmaceutical Transcript: M&A announcement

Collegium Pharmaceutical Press release: M&A announcement

Mar 19, 2026, 9:00 AM EDT - 5 months ago

Collegium Pharmaceutical Press release: M&A announcement

Collegium Pharmaceutical Slides: M&A announcement

Mar 19, 2026, 9:00 AM EDT - 5 months ago

Collegium Pharmaceutical Slides: M&A announcement

Collegium Pharmaceutical to acquire AZSTARYS for $650M in cash

2026-03-19T12:21:54.000Z - 5 months ago

Collegium Pharmaceutical to acquire AZSTARYS for $650M in cash

Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory

Mar 19, 2026, 8:00 AM EDT - 5 months ago

Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory

Collegium Pharmaceutical Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 11, 2026, 9:00 AM EDT - 6 months ago

Collegium Pharmaceutical Transcript: Barclays 28th Annual Global Healthcare Conference

Collegium to Present New Real-World Data at PainConnect 2026

Mar 5, 2026, 8:00 AM EST - 6 months ago

Collegium to Present New Real-World Data at PainConnect 2026

Collegium, Paris Hilton announce ‘Embrace Your Sparkle’ campaign

2026-03-03T13:37:28.000Z - 6 months ago

Collegium, Paris Hilton announce ‘Embrace Your Sparkle’ campaign

Collegium Pharmaceutical Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:00 AM EST - 6 months ago

Collegium Pharmaceutical Earnings Call Transcript: Q4 2025

Collegium Pharmaceutical Annual report: Q4 2025

Feb 26, 2026, 8:00 AM EST - 6 months ago

Collegium Pharmaceutical Annual report: Q4 2025

Collegium Pharmaceutical Earnings release: Q4 2025

Feb 26, 2026, 8:00 AM EST - 6 months ago

Collegium Pharmaceutical Earnings release: Q4 2025

Collegium Pharmaceutical Slides: Q4 2025

Feb 26, 2026, 8:00 AM EST - 6 months ago

Collegium Pharmaceutical Slides: Q4 2025

Collegium Pharmaceutical reports Q4 adjusted EPS $2.04, consensus $2.14

2026-02-26T12:48:39.000Z - 6 months ago

Collegium Pharmaceutical reports Q4 adjusted EPS $2.04, consensus $2.14

Collegium Pharmaceutical sees FY26 product revenue $805M-$825M

2026-02-26T12:48:05.000Z - 6 months ago

Collegium Pharmaceutical sees FY26 product revenue $805M-$825M

Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results

Feb 26, 2026, 7:30 AM EST - 6 months ago

Collegium Reports Fourth Quarter and Full-Year 2025 Financial Results

Collegium Pharmaceutical enters multiyear partnership with Boston Legacy FC

2026-02-23T13:23:08.000Z - 6 months ago

Collegium Pharmaceutical enters multiyear partnership with Boston Legacy FC

Collegium Pharmaceutical price target raised to $58 from $55 at Truist

2026-02-10T14:26:23.000Z - 7 months ago

Collegium Pharmaceutical price target raised to $58 from $55 at Truist

Collegium Pharmaceutical management to meet with Truist

2026-02-05T17:45:46.000Z - 7 months ago

Collegium Pharmaceutical management to meet with Truist

Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference

Jan 15, 2026, 8:00 AM EST - 8 months ago

Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference

Collegium price target lowered to $56 from $58 at Barclays

2026-01-09T12:26:09.000Z - 8 months ago

Collegium price target lowered to $56 from $58 at Barclays

Collegium Pharmaceutical price target raised to $60 from $46 at H.C. Wainwright

2026-01-09T11:16:36.000Z - 8 months ago

Collegium Pharmaceutical price target raised to $60 from $46 at H.C. Wainwright

Collegium Pharmaceutical sees FY26 produce revenue $805M-$825M

2026-01-08T13:11:33.000Z - 8 months ago

Collegium Pharmaceutical sees FY26 produce revenue $805M-$825M

Collegium Provides 2026 Financial Guidance and Business Update

Jan 8, 2026, 8:00 AM EST - 8 months ago

Collegium Provides 2026 Financial Guidance and Business Update

Collegium Pharmaceutical price target raised to $55 from $47 at Truist

2026-01-07T12:25:47.000Z - 8 months ago

Collegium Pharmaceutical price target raised to $55 from $47 at Truist

Collegium Pharmaceutical closes $980M syndicated credit facility

2025-12-30T13:10:23.000Z - 8 months ago

Collegium Pharmaceutical closes $980M syndicated credit facility

Collegium Announces the Closing of $980 Million Syndicated Credit Facility

Dec 30, 2025, 8:00 AM EST - 8 months ago

Collegium Announces the Closing of $980 Million Syndicated Credit Facility

Collegium Pharmaceutical Transcript: Piper Sandler 37th Annual Healthcare Conference

Dec 2, 2025, 2:30 PM EST - 9 months ago

Collegium Pharmaceutical Transcript: Piper Sandler 37th Annual Healthcare Conference

Collegium Pharmaceutical Transcript: Jefferies London Healthcare Conference 2025

Nov 19, 2025, 3:00 AM EST - 9 months ago

Collegium Pharmaceutical Transcript: Jefferies London Healthcare Conference 2025

Collegium Pharmaceutical Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:00 AM EST - 10 months ago

Collegium Pharmaceutical Earnings Call Transcript: Q3 2025

Collegium Pharmaceutical Quarterly report: Q3 2025

Nov 6, 2025, 8:00 AM EST - 10 months ago

Collegium Pharmaceutical Quarterly report: Q3 2025

Collegium Pharmaceutical Earnings release: Q3 2025

Nov 6, 2025, 8:00 AM EST - 10 months ago

Collegium Pharmaceutical Earnings release: Q3 2025

Collegium Pharmaceutical Slides: Q3 2025

Nov 6, 2025, 8:00 AM EST - 10 months ago

Collegium Pharmaceutical Slides: Q3 2025

Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance

Nov 6, 2025, 7:30 AM EST - 10 months ago

Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance

Knight Therapeutics Announces Launch of JORNAY PM™ in Canada

Oct 30, 2025, 5:15 PM EDT - 10 months ago

Knight Therapeutics Announces Launch of JORNAY PM™ in Canada

Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025

Oct 23, 2025, 8:00 AM EDT - 10 months ago

Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025

Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences

Oct 22, 2025, 8:00 AM EDT - 10 months ago

Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences

Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing

Oct 13, 2025, 8:00 AM EDT - 11 months ago

Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing

Collegium Pharmaceutical Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 9, 2025, 10:30 AM EDT - 1 year ago

Collegium Pharmaceutical Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Collegium Pharmaceutical Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 8, 2025, 2:35 PM EDT - 1 year ago

Collegium Pharmaceutical Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting

Aug 25, 2025, 8:00 AM EDT - 1 year ago

Collegium to Present Nine Real-World Data Posters at PAINWeek 2025 Annual Meeting

Collegium Pharmaceutical Earnings Call Transcript: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 1 year ago

Collegium Pharmaceutical Earnings Call Transcript: Q2 2025

Collegium Pharmaceutical Quarterly report: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 1 year ago

Collegium Pharmaceutical Quarterly report: Q2 2025

Collegium Pharmaceutical Earnings release: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 1 year ago

Collegium Pharmaceutical Earnings release: Q2 2025

Collegium Pharmaceutical Slides: Q2 2025

Aug 7, 2025, 8:00 AM EDT - 1 year ago

Collegium Pharmaceutical Slides: Q2 2025

Collegium Reports Second Quarter 2025 Financial Results; Raises 2025 Outlook

Aug 7, 2025, 7:30 AM EDT - 1 year ago

Collegium Reports Second Quarter 2025 Financial Results; Raises 2025 Outlook

Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 24, 2025, 8:00 AM EDT - 1 year ago

Collegium to Report Second Quarter 2025 Financial Results on August 7, 2025

Collegium Announces $150 Million Share Repurchase Program

Jul 7, 2025, 8:00 AM EDT - 1 year ago

Collegium Announces $150 Million Share Repurchase Program

Collegium Pharmaceutical Transcript: Jefferies Global Healthcare Conference 2025

Jun 5, 2025, 1:25 PM EDT - 1 year ago

Collegium Pharmaceutical Transcript: Jefferies Global Healthcare Conference 2025

Collegium Pharmaceutical Slides: FY 2025

Jun 5, 2025, 1:25 PM EDT - 1 year ago

Collegium Pharmaceutical Slides: FY 2025

Collegium Announces $25 Million Accelerated Share Repurchase Program

May 12, 2025, 8:05 AM EDT - 1 year ago

Collegium Announces $25 Million Accelerated Share Repurchase Program

Collegium Pharmaceutical Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Collegium Pharmaceutical Earnings Call Transcript: Q1 2025

Collegium Pharmaceutical Quarterly report: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Collegium Pharmaceutical Quarterly report: Q1 2025

Collegium Pharmaceutical Earnings release: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Collegium Pharmaceutical Earnings release: Q1 2025

Collegium Pharmaceutical Slides: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Collegium Pharmaceutical Slides: Q1 2025

Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress

May 8, 2025, 4:01 PM EDT - 1 year ago

Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress

Collegium to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 24, 2025, 8:00 AM EDT - 1 year ago

Collegium to Report First Quarter 2025 Financial Results on May 8, 2025

Collegium Pharmaceutical Transcript: 24th Annual Needham Virtual Healthcare Conference

Apr 8, 2025, 9:30 AM EDT - 1 year ago

Collegium Pharmaceutical Transcript: 24th Annual Needham Virtual Healthcare Conference

Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference

Collegium Pharmaceutical Proxy statement: Proxy Filing

Mar 28, 2025, 8:00 AM EDT - 1 year ago

Collegium Pharmaceutical Proxy statement: Proxy Filing

Collegium Pharmaceutical Proxy statement: Proxy Filing

Mar 28, 2025, 8:00 AM EDT - 1 year ago

Collegium Pharmaceutical Proxy statement: Proxy Filing

Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine's Annual Meeting

Mar 27, 2025, 8:00 AM EDT - 1 year ago

Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine's Annual Meeting

Collegium Announces Updates to its Board of Directors and Executive Leadership Team

Mar 17, 2025, 7:00 AM EDT - 1 year ago

Collegium Announces Updates to its Board of Directors and Executive Leadership Team

Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care

Mar 10, 2025, 6:57 PM EDT - 1 year ago

Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care

Collegium Pharmaceutical Earnings Call Transcript: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

Collegium Pharmaceutical Earnings Call Transcript: Q4 2024

Collegium Pharmaceutical Annual report: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

Collegium Pharmaceutical Annual report: Q4 2024

Collegium Pharmaceutical Earnings release: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

Collegium Pharmaceutical Earnings release: Q4 2024

Collegium Pharmaceutical Slides: Q4 2024

Feb 27, 2025, 4:30 PM EST - 1 year ago

Collegium Pharmaceutical Slides: Q4 2024

Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results

Feb 27, 2025, 4:01 PM EST - 1 year ago

Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results

Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025

Feb 13, 2025, 8:00 AM EST - 1 year ago

Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025

Collegium Provides 2025 Financial Guidance and Business Update

Jan 8, 2025, 8:00 AM EST - 1 year ago

Collegium Provides 2025 Financial Guidance and Business Update

Collegium Pharmaceutical Transcript: Piper Sandler 36th Annual Healthcare Conference

Dec 5, 2024, 1:00 PM EST - 1 year ago

Collegium Pharmaceutical Transcript: Piper Sandler 36th Annual Healthcare Conference

Collegium Pharmaceutical Transcript: Jefferies London Healthcare Conference 2024

Nov 19, 2024, 8:30 AM EST - 1 year ago

Collegium Pharmaceutical Transcript: Jefferies London Healthcare Conference 2024

Knight Therapeutics Announces Health Canada Approval for JORNAY PM™ to Treat Attention-Deficit Hyperactivity Disorder (ADHD)

Nov 14, 2024, 4:30 PM EST - 1 year ago

Knight Therapeutics Announces Health Canada Approval for JORNAY PM™ to Treat Attention-Deficit Hyperactivity Disorder (ADHD)

Collegium Pharmaceutical Earnings Call Transcript: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Collegium Pharmaceutical Earnings Call Transcript: Q3 2024

Collegium Pharmaceutical Quarterly report: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Collegium Pharmaceutical Quarterly report: Q3 2024

Collegium Pharmaceutical Earnings release: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Collegium Pharmaceutical Earnings release: Q3 2024

Collegium Pharmaceutical Slides: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Collegium Pharmaceutical Slides: Q3 2024

Collegium Reports Record Third Quarter 2024 Financial Results

Nov 7, 2024, 4:02 PM EST - 1 year ago

Collegium Reports Record Third Quarter 2024 Financial Results

Collegium Pharmaceutical Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Sep 9, 2024, 12:30 PM EDT - 2 years ago

Collegium Pharmaceutical Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Aug 30, 2024, 8:00 AM EDT - 2 years ago

Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Collegium Pharmaceutical Earnings Call Transcript: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

Collegium Pharmaceutical Earnings Call Transcript: Q2 2024

Collegium Pharmaceutical Quarterly report: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

Collegium Pharmaceutical Quarterly report: Q2 2024

Collegium Pharmaceutical Earnings release: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

Collegium Pharmaceutical Earnings release: Q2 2024

Collegium Pharmaceutical Slides: Q2 2024

Aug 8, 2024, 4:30 PM EDT - 2 years ago

Collegium Pharmaceutical Slides: Q2 2024

Collegium Reports Second Quarter 2024 Financial Results

Aug 8, 2024, 4:01 PM EDT - 2 years ago

Collegium Reports Second Quarter 2024 Financial Results

Collegium Pharmaceutical Transcript: M&A Announcement

Jul 29, 2024, 8:30 AM EDT - 2 years ago

Collegium Pharmaceutical Transcript: M&A Announcement

Collegium Pharmaceutical Press release: M&A Announcement

Jul 29, 2024, 8:30 AM EDT - 2 years ago

Collegium Pharmaceutical Press release: M&A Announcement

Collegium Pharmaceutical Slides: M&A Announcement

Jul 29, 2024, 8:30 AM EDT - 2 years ago

Collegium Pharmaceutical Slides: M&A Announcement

Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology

Jul 29, 2024, 6:00 AM EDT - 2 years ago

Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology

Collegium Pharmaceutical Transcript: Jefferies 2024 Global Healthcare Conference

Jun 5, 2024, 9:30 AM EDT - 2 years ago

Collegium Pharmaceutical Transcript: Jefferies 2024 Global Healthcare Conference

Collegium to Participate in Jefferies Global Healthcare Conference

May 29, 2024, 8:00 AM EDT - 2 years ago

Collegium to Participate in Jefferies Global Healthcare Conference

Collegium Announces $35 Million Accelerated Share Repurchase Program

May 13, 2024, 8:00 AM EDT - 2 years ago

Collegium Announces $35 Million Accelerated Share Repurchase Program

Collegium Pharmaceutical Proxy statement: Proxy Filing

May 10, 2024, 8:00 AM EDT - 2 years ago

Collegium Pharmaceutical Proxy statement: Proxy Filing

Collegium Pharmaceutical Earnings Call Transcript: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Collegium Pharmaceutical Earnings Call Transcript: Q1 2024

Collegium Pharmaceutical Quarterly report: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Collegium Pharmaceutical Quarterly report: Q1 2024

Collegium Pharmaceutical Earnings release: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Collegium Pharmaceutical Earnings release: Q1 2024

Collegium Pharmaceutical Slides: Q1 2024

May 9, 2024, 4:30 PM EDT - 2 years ago

Collegium Pharmaceutical Slides: Q1 2024

Collegium Reports First Quarter 2024 Financial Results

May 9, 2024, 4:02 PM EDT - 2 years ago

Collegium Reports First Quarter 2024 Financial Results

Collegium to Report First Quarter 2024 Financial Results on May 9, 2024

Apr 25, 2024, 8:00 AM EDT - 2 years ago

Collegium to Report First Quarter 2024 Financial Results on May 9, 2024

Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026

Apr 11, 2024, 8:00 AM EDT - 2 years ago

Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026

Collegium Pharmaceutical Transcript: 23rd Annual Needham Virtual Healthcare Conference

Apr 10, 2024, 3:45 PM EDT - 2 years ago

Collegium Pharmaceutical Transcript: 23rd Annual Needham Virtual Healthcare Conference

Collegium Pharmaceutical Proxy statement: Proxy Filing

Apr 5, 2024, 8:00 AM EDT - 2 years ago

Collegium Pharmaceutical Proxy statement: Proxy Filing

Collegium Pharmaceutical Proxy statement: Proxy Filing

Apr 5, 2024, 8:00 AM EDT - 2 years ago

Collegium Pharmaceutical Proxy statement: Proxy Filing

Collegium Pharmaceutical Earnings Call Transcript: Q4 2023

Feb 22, 2024, 4:30 PM EST - 2 years ago

Collegium Pharmaceutical Earnings Call Transcript: Q4 2023

Collegium Pharmaceutical Annual report: Q4 2023

Feb 22, 2024, 4:30 PM EST - 2 years ago

Collegium Pharmaceutical Annual report: Q4 2023

Collegium Pharmaceutical Earnings release: Q4 2023

Feb 22, 2024, 4:30 PM EST - 2 years ago

Collegium Pharmaceutical Earnings release: Q4 2023

Collegium Pharmaceutical Slides: Q4 2023

Feb 22, 2024, 4:30 PM EST - 2 years ago

Collegium Pharmaceutical Slides: Q4 2023

Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results

Feb 22, 2024, 4:09 PM EST - 2 years ago

Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results

Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024

Feb 8, 2024, 8:00 AM EST - 2 years ago

Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024

Collegium Pharmaceutical Slides: Investor Presentation

Jan 2, 2024, 9:00 AM EST - 2 years ago

Collegium Pharmaceutical Slides: Investor Presentation

Collegium Pharmaceutical Transcript: The Piper Sandler 35th Annual Healthcare Conference

Nov 28, 2023, 4:00 PM EST - 2 years ago

Collegium Pharmaceutical Transcript: The Piper Sandler 35th Annual Healthcare Conference

Appeals Court Upholds PTAB's Finding of Invalidity of Purdue's 961 Patent

Nov 27, 2023, 8:00 AM EST - 2 years ago

Appeals Court Upholds PTAB's Finding of Invalidity of Purdue's 961 Patent

Collegium Pharmaceutical Transcript: 14th Annual Jefferies London Healthcare Conference 2023

Nov 14, 2023, 4:30 AM EST - 2 years ago

Collegium Pharmaceutical Transcript: 14th Annual Jefferies London Healthcare Conference 2023

Collegium Pharmaceutical Earnings Call Transcript: Q3 2023

Nov 7, 2023, 4:30 PM EST - 2 years ago

Collegium Pharmaceutical Earnings Call Transcript: Q3 2023

Collegium Pharmaceutical Quarterly report: Q3 2023

Nov 7, 2023, 4:30 PM EST - 2 years ago

Collegium Pharmaceutical Quarterly report: Q3 2023

Collegium Pharmaceutical Earnings release: Q3 2023

Nov 7, 2023, 4:30 PM EST - 2 years ago

Collegium Pharmaceutical Earnings release: Q3 2023

Collegium Pharmaceutical Slides: Q3 2023

Nov 7, 2023, 4:30 PM EST - 2 years ago

Collegium Pharmaceutical Slides: Q3 2023

Collegium Reports Third Quarter 2023 Financial Results

Nov 7, 2023, 4:01 PM EST - 2 years ago

Collegium Reports Third Quarter 2023 Financial Results

JR603
JR603 Sep. 10 at 4:01 PM
$COLL YIKES !
0 · Reply
lolloalb
lolloalb Aug. 31 at 8:16 PM
$COLL No sense… this company is seriously undervalued. The current share price simply doesn’t reflect the strength of the business, its cash generation and the value of its portfolio. The recent sell-off looks completely disconnected from the underlying fundamentals. At these levels, the market seems to be pricing in a much worse scenario than the one the company is actually facing. Long-term, I still believe there is significant upside.
0 · Reply
JR603
JR603 Aug. 31 at 4:38 PM
$COLL Holly Molly ...... does this mean another $50M buyback is coming next? Why is this company so unappreciated and unrecognized?
0 · Reply
jewell69
jewell69 Aug. 27 at 5:04 PM
yo me llamo "Claire Voyant" $COLL re-entry today. s yesterday. 08/27/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 352 $26.58 -$9,356.16 More 08/26/2026 Sell Edit cost basis method COLL COLLEGIUM PHARMACEUTICAL 351 $28.04 $0.27 $9,841.77 More 08/25/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 351 $27.58 -$9,680.58 More 08/24/2026 Sell COLL COLLEGIUM PHARMACEUTICAL 350 $27.80 $0.27 $9,729.73 More 08/20/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 350 $27.74 -$9,709.00 More 08/18/2026 Sell COLL COLLEGIUM PHARMACEUTICAL 30 $28.34 $0.03 $850.17 More 08/17/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 30 $28.25 -$847.50 More 08/17/2026 Sell COLL COLLEGIUM PHARMACEUTICAL 201 $28.85 $0.16 $5,798.69 More 08/14/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 201 $27.98 -$5,623.98
0 · Reply
jewell69
jewell69 Aug. 26 at 3:08 PM
$COLL s 351 28.04 11:03 am edt 8/26 (horray ! limit order placed at 27.98 ) paid 27.58 yesterday
0 · Reply
jewell69
jewell69 Aug. 25 at 5:20 PM
$COLL narrow trading range, UGH ! Got Opium ? re-entry. ps we were trading this in the 43's not 2 long ago 08/25/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 351 $27.58 -$9,680.58 More 08/24/2026 Sell Edit cost basis method COLL COLLEGIUM PHARMACEUTICAL 350 $27.80 $0.27 $9,729.73 More 08/20/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 350 $27.74 -$9,709.00
0 · Reply
CHenry18
CHenry18 Aug. 25 at 1:20 AM
$COLL millenium just doubled its long position and filed a 13G
0 · Reply
jewell69
jewell69 Aug. 20 at 4:12 PM
$COLL Got Opium ? re-entry 12:11 pm edt 8/20 bigger position this time around. 08/20/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 350 $27.74 -$9,709.00 More 08/18/2026 Sell COLL COLLEGIUM PHARMACEUTICAL 30 $28.34 $0.03 $850.17 More 08/17/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 30 $28.25 -$847.50 More 08/17/2026 Sell COLL COLLEGIUM PHARMACEUTICAL 201 $28.85 $0.16 $5,798.69 More 08/14/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 201 $27.98 -$5,623.98 More 08/13/2026 Sell COLL COLLEGIUM PHARMACEUTICAL 200 $28.32 $0.16 $5,663.84
0 · Reply
jewell69
jewell69 Aug. 13 at 7:13 PM
$COLL catching a falling knife SOMETIMES results in bloody hands. lost on this one. fwiw we b 100 during the day, and b 100 on a mkt on close order. GOT OPIUM ? non-addictive pain medicine. 2 hot 2 handle (it was at 44 in early february) 08/13/2026 Sell Edit cost basis method COLL COLLEGIUM PHARMACEUTICAL 200 $28.32 $0.16 $5,663.84 More 08/06/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 100 $29.11 -$2,911.00 More 08/06/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 100 $30.28 -$3,028.00
0 · Reply
DutchGolden
DutchGolden Aug. 13 at 7:09 PM
$COLL why are options so expensive for a $20 stock
1 · Reply
JR603
JR603 Aug. 13 at 6:23 PM
$COLL Collegium Pharmaceutical Inc (Nasdaq: COLL) stock rose sharply on August 13, 2026, after announcing a $50 million accelerated share repurchase (ASR) agreement with Jefferies LLC as part of an existing board-authorized buyback program. Collegium Pharmaceutical Key Details of the Buyback Program Size: $50 million executed immediately out of a $150 million authorization. Initial Share Delivery: Immediate receipt of 1,556,420 shares based on the previous close of $25.70. Management Rationale: CEO Vikram Karnani stated the company believes the current market valuation does not reflect the true underlying business strength or growth.
0 · Reply
JR603
JR603 Aug. 13 at 6:05 PM
$COLL Per AI - Collegium Pharmaceutical Inc (Nasdaq: COLL) stock rose sharply on August 13, 2026, after announcing a $50 million accelerated share repurchase (ASR) agreement with Jefferies LLC as part of an existing board-authorized buyback program. Collegium Pharmaceutical Key Details of the Buyback Program Size: $50 million executed immediately out of a $150 million authorization. Initial Share Delivery: Immediate receipt of 1,556,420 shares based on the previous close of $25.70. Management Rationale: CEO Vikram Karnani stated the company believes the current market valuation does not reflect the true underlying business strength or growth.
0 · Reply
theveteram1nd
theveteram1nd Aug. 13 at 2:27 PM
500% POTENTIAL $COLL 30 Call 8/21 avg .55
0 · Reply
theveteram1nd
theveteram1nd Aug. 13 at 2:26 PM
HIGH CONFIDENCE $COLL 30 Call 8/21 avg .55
0 · Reply
Itinerant
Itinerant Aug. 10 at 4:00 PM
$COLL The Azstarys revenues are for only half the quarter. Annualized, the acquisition price was reasonable. The stock is cheap.
0 · Reply
Itinerant
Itinerant Aug. 10 at 3:39 PM
$COLL COLL paid $700 million for Azstarys which has modest revenue. I guess that they think they are able to really expand marketing, but I am a bit skeptical of that. The market is clearly dubious. JMO
0 · Reply
jewell69
jewell69 Aug. 8 at 1:53 AM
$COLL I b this on a bad bad down -17% day twice on Thursday 8/6 08/06/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 100 $29.11 -$2,911.00 More 08/06/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 100 $30.28 -$3,028.00 up more than eyelash today friday 8/7 to 29.47 +1.24% for the day.
0 · Reply
jewell69
jewell69 Aug. 6 at 8:07 PM
$COLL Collegium Pharmaceuticals (Got Opium ?) we decided to buy 100 today when we found it (zumba class always distracts me / us, ha ha) and we b 100 more on a market close order which was the cheaper buy price. by the way today's low was 28.90 the stock was down 18 /12 % today Thursday, 8/6 08/06/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 100 $29.11 -$2,911.00 More 08/06/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 100 $30.28 -$3,028.00
0 · Reply
jewell69
jewell69 Aug. 6 at 5:40 PM
$COLL re-entry 8/6 1:38 pm EDT 100, also entered b 100 mkt on close
0 · Reply
jewell69
jewell69 Aug. 6 at 5:35 PM
$COLL is down -15.5% today Thursday 8/6 to 30.12 Luckily I didn't chase it. it went as high as 37.48 on 7/6, and 6 months ago it closed at 47.21 on 2/10. I will probably buy. non-addictive pain medicine. trade history: 05/20/2026 Sell COLL COLLEGIUM PHARMACEUTICAL 5 $33.53 $167.65 More 05/19/2026 Sell COLL COLLEGIUM PHARMACEUTICAL 150 $33.50 $0.13 $5,024.87 More 05/19/2026 Buy COLL COLLEGIUM PHARMACEUTICAL 155 $33.3526 -$5,169.65 More 05/18/2026 Sell COLL COLLEGIUM PHARMACEUTICAL 202 $34.69 $0.18 $7,007.20
0 · Reply
EarningsInsider
EarningsInsider Aug. 6 at 12:45 PM
https://www.marketbeat.com/earnings/reports/2026-8-6-collegium-pharmaceutical-inc-stock/ $COLL Collegium Pharmaceutical Earnings Transcrip
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 6 at 11:39 AM
$COLL Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.46 down -221.05% YoY • Reported revenue of $199.88M up 6.32% YoY • Collegium Pharmaceutical updated its full-year 2026 guidance, now expecting product revenues between $825 million and $855 million and adjusted EBITDA between $445 million and $470 million for the full year.
0 · Reply